Skip to main content
MBAI
NASDAQ Industrial Applications And Services

Check-Cap Sets $12.5M Offering Terms at $8.72/Share to Fund MBody AI Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$9
Mkt Cap
$11.788M
52W Low
$4.201
52W High
$27.44
52W Position info
114% above low
Off High info
67% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

MBAI has more than doubled off its 52-week low of $4.201 on elevated volume (2.3× avg).

Summary

Check-Cap's amended F-1 sets terms for a $12.5 million offering at $8.72 per share to fund its merger with MBody AI, with proceeds allocated to robotics and platform development.


Key Events · Financing and Capital Events · MBAI

  • Offering Terms Finalized

    Check-Cap will sell 1,433,486 ordinary shares at an assumed price of $8.72 per share, raising $12.5 million before expenses. The underwriter has a 30-day option to purchase up to 215,022 additional shares.

  • Dilution Impact

    New investors will own 9.4% of the post-merger company. The offering price represents an 87.4% premium over the pro forma net tangible book value of $1.10 per share, resulting in immediate dilution of $7.62 per share to new investors.

  • Use of Proceeds

    Net proceeds of $11.4 million will be allocated: $1.1M for merger fees, $5.7M for robotic systems, $1.1M for inventory, $2.3M for platform development, and $1.1M for working capital.

  • Merger Funding

    The offering is contingent on Nasdaq listing and is intended to fund the pending merger with MBody AI, expected to close in Q3 2026. The merger will result in MBody AI shareholders owning 90% of the combined company.


Analysis · MBAI · Industrial Applications And Services

Check-Cap has finalized terms for its firm commitment public offering, reducing the size from $15 million to $12.5 million and setting an assumed price of $8.72 per share. The offering is critical to fund the pending merger with MBody AI and support the combined company's robotics deployments. The filing reveals significant dilution: new investors will own 9.4% of the post-merger company, and the offering price is 87.4% above the pro forma net tangible book value per share, meaning new investors pay a substantial premium over the company's book value. The deal is underwritten by Northland Securities, and proceeds are earmarked for merger costs, robotic systems, platform development, and working capital. The offering is contingent on Nasdaq listing, and the merger is expected to close in Q3 2026.

At the time of this filing, MBAI was trading at $9.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $11.8M. The 52-week trading range was $4.20 to $27.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MBAI - Latest Insights

MBAI
Aug 11, 2026, 11:37 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.27
Real-time Price: $8.72 info
Change: Reverse Stock Split info
Market Cap: $11.788M info
MBAI
Aug 07, 2026, 6:51 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $8.72 info
Change: Reverse Stock Split info
Market Cap: $11.788M info
MBAI
Aug 06, 2026, 4:49 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.34
Real-time Price: $8.72 info
Change: Reverse Stock Split info
Market Cap: $11.788M info
MBAI
Aug 05, 2026, 9:00 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $8.72 info
Change: Reverse Stock Split info
Market Cap: $11.788M info
MBAI
Jul 24, 2026, 5:38 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $8.72 info
Change: Reverse Stock Split info
Market Cap: $11.788M info